Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases

Acta Radiologica

Volumn 57, Issue 1, 2016, Pages 58-65

  Chang, Connie Y ^a   Gill, Corey M ^a   Joseph Simeone, F ^a   Taneja, Atul K ^a   Huang, Ambrose J ^a   Torriani, Martin ^a   Bredella, Miriam A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Neoplasm metastasis; Radionuclide imaging; Radionuclide emission computed tomography; Sensitivity and specificity

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; DISEASES; MAGNETIC RESONANCE IMAGING; MUSCULOSKELETAL SYSTEM; NUCLEAR MEDICINE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PULMONARY DISEASES; RADIOISOTOPES;

DIAGNOSTIC ACCURACY; EMISSION COMPUTED TOMOGRAPHY; FLUORINE-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHIES; METASTATIC DISEASE; NEOPLASM METASTASIS; RADIONUCLIDE IMAGING; SCIENTIFIC LITERATURE; SENSITIVITY AND SPECIFICITY;

BONE;

FLUORODEOXYGLUCOSE F 18; MEDRONATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER STAGING; CHILD; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; BONE TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING; SECONDARY; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M MEDRONATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84960919697     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1177/0284185114564438     Document Type: Article

References (32)

1. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006;12: 6243s-6249s.
2. Li S, Peng Y, Weinhandl ED, et al. Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clin Epidemiol 2012;4:87-93.
3. Soderlund V. Radiological diagnosis of skeletal metas-tases. Eur Radiol 1996;6:587-595.
4. Clemons M, Gelmon KA, Pritchard KI, et al. Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art. Curr Oncol 2012;19:259-268.
5. Hamaoka T, Madewell JE, Podoloff DA, et al. Bone imaging in metastatic breast cancer. J Clin Oncol 2004; 22:2942-2953.
6. Lewis P, Griffin S, Marsden P, et al. Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet 1994; 344:1265-1266.
7. Valk PE, Pounds TR, Hopkins DM, et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg 1995;60: 1573-1581; discussion 1581-1582.
8. Bury T, Barreto A, Daenen F, et al. Fluorine-18 deoxy-glucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 1998;25:1244-1247.
9. Moon DH, Maddahi J, Silverman DH, et al. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. J Nucl Med 1998;39:431-435.
10. Costelloe CM, Rohren EM, Madewell JE, et al. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol 2009;10:606-614.
11. Cook GJ, Houston S, Rubens R, et al. Detection of bone metastases in breast cancer by 18-FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 1998;16:3375-3379.
12. Gallowitsch H-J, Kresnik E, Gasser J, et al. F-18 fluor-odeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging. Invest Radiol 2003;38: 250-256.
13. Huyge V, Garcia C, Vanderstappen A, et al. Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET. Clin Nucl Med 2009;34:417-420.
14. Moog F, Kotzerke J, Reske SN. FDG PET can replace bone scintigraphy in primary staging of malignant lymph-oma. J. Nucl Med 1999;40:1407-1413.
15. Ozulker T, Kucukoz Uzun A, et al. Comparison of (18)F-FDG PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients. Nucl Med Commun 2010;31:597-603.
16. Shie P, Cardarelli R, Brandon D, et al. Meta-analysis: comparison of F-18 Fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer. Clin Nucl Med 2008;33:97-101.
17. Chang M-C, Chen J-H, Liang J-A, et al. Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer. Acad Radiol 2012;19:349-357.
18. Coleman RE. Skeletal complications of malignancy. Cancer 1997;80:1588-1594.
19. Coleman RE. Management of bone metastases. Oncologist 2000;5:463-470.
20. Napoli LD, Hansen HH, Muggia FM, et al. The incidence of osseous involvement in lung cancer, with special reference to the development of osteoblastic changes. Radiology 1973;108:17-21.
21. Cowan RJ, Young KA. Evaluation of serum alkaline phosphatase determination in patients with positive bone scans. Cancer 1973;32:887-889.
22. Bhoil A, Gayana S, Sood A, et al. Hybrid single photon emission computed tomography/computed tomography sulphur colloid scintigraphy in focal nodular hyperplasia. World J Nucl Med 2013;12:124-125.
23. Kannivelu A, Loke KSH, Kok TY, et al. The role of PET/CT in the evaluation of skeletal metastases. Semin Musculoskelet Radiol 2014;18:149-165.
24. Ranade R, Thapa P, Basu S. Adrenal metastasis from differentiated thyroid carcinoma documented on post-therapy (131)I scan: A case based discussion. World J Radiol 2014;6:56-61.
25. Mansberg R, Ho B, Bui C, et al. False positive F-18 FDG PET/CT of skeletal metastasis due to solitary eosinophilic granuloma. Mol Imaging Radionucl Ther 2013;22: 103-105.
26. Kamaleshwaran KK, Mohanan V, Madhavan D, et al. Technetium-99m methylene diphosphonate uptake in the brachialis muscle hematoma in a patient with prostate cancer and coagulation disorder mimicking bone metastasis evaluated by single-photon emission tomography-computed tomography/computed tomography. Indian J Nucl Med 2013;28:230-231.
27. Kamaleshwaran KK, Subramanian PV, Natarajan S, et al. Bone metastasis from a neuroendocrine tumor detected by 99m-technetium-hydrazinonicotinyl-Tyr3-octreotide single-photon emission computed tomography/computed tomography. Indian J Nucl Med 2013; 28:187-188.
28. Groheux D, Ferre R, Rubello D, et al. Breast cancer patient with an uncommon lymphatic drainage evidenced by SPECT/CT. Clin Nucl Med 2014;39:e176-179.
29. Chakraborty D, Bhattacharya A, Mete UK, et al. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma. Clin Nucl Med 2013;38:616-621.
30. Sodee DB, Sodee AE, Bakale G. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer. Semin Nucl Med 2007;37:17-28.
31. 18F-FDG PET/CT in the detection of metastatic thyroid cancer. Eur J Nucl Med Mol Imaging 2011;38:1459-1468.
32. Ulaner GA, Magnan H, Healey JH, et al. Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed? Am J Roentgenol 2014;202:859-867.